Shanghai Shyndec Pharmaceutical Co (SHSE:600420) Construction In Progress : ¥139 Mil (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Shanghai Shyndec Pharmaceutical Co Construction In Progress?

Shanghai Shyndec Pharmaceutical Co's quarterly construction in progress declined from Sep. 2024 (¥149 Mil) to Dec. 2024 (¥143 Mil) and declined from Dec. 2024 (¥143 Mil) to Mar. 2025 (¥139 Mil).

Shanghai Shyndec Pharmaceutical Co's annual construction in progress declined from Dec. 2022 (¥642 Mil) to Dec. 2023 (¥101 Mil) but then increased from Dec. 2023 (¥101 Mil) to Dec. 2024 (¥143 Mil).

Shanghai Shyndec Pharmaceutical Co Construction In Progress Historical Data

The historical data trend for Shanghai Shyndec Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Shyndec Pharmaceutical Co Construction In Progress Chart

Shanghai Shyndec Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

Get a 7-Day Free Trial

575.85

585.52

642.37

101.35

142.68

Shanghai Shyndec Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Construction In Progress	Get a 7-Day Free Trial															111.54	155.32	148.73	142.68	139.11

Shanghai Shyndec Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Shanghai Shyndec Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Shyndec Pharmaceutical Co Ltd (SHSE:600420) » Definitions » Construction In Progress

Traded in Other Exchanges

N/A

Address

No.1320 Beijinxi Road, Shanghai, CHN, 200040

Website

http://www.shyndec.com

Shanghai Shyndec Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical preparations, biological pharmaceuticals, chemical raw materials, and Chinese medicine formulations in China and internationally. It provides biological and chemical raw material medicines, microbial fermentation products and tablets, capsules, granules, injections, suspensions, and suppositories, as well as ointments, including product formulations.

Executives

Li Hao	senior management
Ni Feng	Director
Li Xian Lin	senior management
Hao Chao Feng	senior management
Lian Wan Yong	Director
Han Yan Lin	Director
Yang Wen Ming	Supervisors
Feng Ming	Director

Shanghai Shyndec Pharmaceutical Co Headlines

No Headlines